XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.4
EQUITY
6 Months Ended
Dec. 31, 2020
Equity [Abstract]  
EQUITY
Restricted Stock Units  

Restricted

Stock Units

   

Weighted Average Grant Date Fair Value

($/share)

 
             
Outstanding at September 30, 2020     837,012     $ 5.35  
   Granted     -          
   Vested and issued     (3,402 )     7.35  
   Forfeited     -          
Outstanding at December 31, 2020     833,610     $ 5.35  

 

As of December 31, 2020, there were 10,788 stock units outstanding that had vested but for which shares of Common Stock had not yet been issued pursuant to the terms of the agreement.

 

As of December 31, 2020, there was approximately $4.5 million of unrecognized stock-based compensation expense under our equity compensation plans, which is expected to be recognized on a straight-line basis over a weighted average period of 2.98 years.

 

Warrants

 

 The following table summarizes information about warrants outstanding and exercisable at December 31, 2020:

 

  Warrants Outstanding     Warrants Exercisable  
  at December 31, 2020     at December 31, 2020  
 

 Range of

exercise prices

Warrants

   

Number

outstanding

   

Weighted average

remaining contractual

life (years)

   

Weighted average

exercise price

   

Number

exercisable

   

Weighted average

exercise price

 
  $ 4.00       1,085,068       2.10     $ 4.00       1,085,068     $ 4.00  
  $ 10.00       23,737       2.07     $ 10.00       23,737     $ 10.00  
            1,108,805       2.10     $ 4.13       1,108,805     $ 4.13  

 

During the six months ended December 31, 2020, the Company’s Board of Directors approved the modification to extend the expiration dates of the Company's existing January 26, 2020 and February 6, 2020 warrants by an additional three years. Accordingly, all the Company’s outstanding warrants are now set to expire in the quarter ending March 31, 2023.

 

Preferred Stock

 

The Company’s articles of incorporation, as amended, currently authorize the issuance of up to 30,000,000 shares of “blank check” preferred stock, par value $0.01 per share ("Preferred Stock") with designations, rights, and preferences as may be determined from time-to-time by the Company’s Board of Directors (the “Board”), of which 700,000 shares are currently designated as Series B Preferred Stock (“Series B Preferred”) and 550,000 shares are designated as Series B-1 Preferred Stock (“Series B-1 Preferred”). As of December 31, 2020, a total of 625,375 shares of Series B Preferred and 212,402 shares of Series B-1 Preferred were issued and outstanding, respectively. Both classes of Series B Preferred Stock pay dividends at a rate of 7% per annum if paid in cash, or 9% if paid in additional shares of Series B Preferred (“PIK Shares”), with the form of dividend payment to be determined by the Company.

  

The Company does business with some of the largest retailers and wholesalers in the world. Management believes the Series B-1 Preferred favorably impacts the Company’s overall cost of capital in that it is: (i) perpetual and, therefore, an equity instrument that positively impacts the Company’s coverage ratios, (ii) offers the flexibility of a paid-in-kind (“PIK”) payment option, and (iii) is without covenants. After exploring alternative options for redeeming the Series B-1 Preferred, management determined that alternative financing options were significantly more expensive or would negatively impact the Company’s net cash position, which management believes could cause customer concerns and weaken the Company’s ability to attract new business.